Related Experiment Video
Updated: Oct 25, 2026

Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
Capillary self-blood collection for centralized testing - a pan-European cross-sectional pilot study
Dominik Schröder1, Louis Kuhnke2, Linda Hoffmeister1
1Department of General Practice, University Medical Center, Göttingen, Germany.
Background:
Self-collection of capillary blood allows study participants to provide samples without in-person healthcare contact and to return them by mail to a central laboratory. We evaluated the feasibility and analytical agreement of internationally mailed self-collected capillary blood in a pan-European setting.
Methods:
In this cross-sectional pilot study, adults attending the INFORM EU plenary meeting in Hannover, Germany provided two capillary blood samples: one sample was mailed from their country of residence (capillary mail-in sample, CMS); the other was analyzed within 24 h (capillary comparison sample, CCS). Thyroid-stimulating hormone (TSH), C-reactive protein (CRP), creatinine, and alanine aminotransferase (ALT) were measured. Agreement was assessed with correlation coefficients, Deming and Passing-Bablok regression, and Bland-Altman analysis.
Results:
Of 66 participants, 49 (74.2%) returned a mailed sample after a median transit of 8 days (Q25-Q75: 5-12). Analytically valid pairs were available for 17 (TSH), 16 (ALT), 16 (creatinine), and 19 (CRP) participants. Agreement was high for CRP (r and CCC = 1.00) and good for TSH (r = 0.90; CCC = 0.88). Creatinine showed a strong correlation but low concordance (r = 0.85; CCC = 0.19) with a proportional bias, and ALT showed the weakest agreement (r = 0.54; CCC = 0.21) and largest bias. Longer transit was associated with higher ALT differences (ρ = 0.57).
Conclusions:
International postal return of self-collected capillary blood was achievable, and the main constraint was insufficient plasma volume rather than delivery. CRP, and to a lesser extent TSH, reached acceptable agreement, whereas ALT and creatinine did not. Given the small number of valid samples and healthy study population, these findings need further confirmation.
German Clinical Trials Register Identifier:
DRKS00033172 on January 30th, 2024.
More Related Videos
11:31Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting
Published on: November 30, 2015
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021